Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Diagnostics In 2016: From Alere To Zika

Jan 25 2017

• By Mark Ratner

IV1701_DX-Trends_1200x675

Related Content

Science Matters: Insights Into Gut-Brain Signaling Raise Hopes For Treating Neurological Disorders

Jan 10 2017

Matchmaking And Integration In The New World Of Diagnostics M&A

Apr 09 2013

When Illumina Buys Roche: The Dawning Of The Era Of Diagnostics Dominance

Jul 28 2014

Short-Term US Funding Bill Passes With $1.1bn In Emergency Zika Funds

Sep 29 2016

Industry: Next-Gen Sequencing Draft Guidances Have Good Ideas But Need Tweaks

Oct 17 2016

Liquid Biopsy, Particle-Beam Radiotherapy Get 'Moonshot' Commitments

Oct 17 2016

Diagnostics In 2015: Past Trends Coalesce, New Roads Open

Jan 21 2016

Rapid Infectious Disease Testing Picks Up Speed

Jul 28 2016

How Immuno-Oncology Is Turning Biomarker Development On Its Head

Oct 17 2016

FDA Puts Lab-Developed Test Oversight Plans On Hold

Nov 18 2016

Abbott Steps Up Effort To Abandon Alere Deal

Dec 07 2016

Related Companies

Danaher Corp.

Luminex Corporation

Danaher Corp.

Abbott

Alere, Inc.

Illumina, Inc.

Foundation Medicine, Inc.

Thermo Fisher Scientific

Personal Genome Diagnostics Inc.

Eli Lilly and Company

Pfizer Inc.

Merck & Co., Inc.

Bristol Myers Squibb Company

Roche Holding AG

Nestle Health Science

Quest Diagnostics Incorporated

Siemens AG

Siemens AG

Additional Topics

Innovation Medical Device In Vitro Diagnostics

More from Innovation

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window